CompletedNCT03197493
Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)
PHASE2 · 35 planned enrolment
- Countries listed
- 1
- Registry update
- September 12, 2025
immortal.lifeTrial registrations containing the exact intervention label carbidopa-levodopa 25-100 mg.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 35 planned enrolment
PHASE2 · 0 planned enrolment